Macro Minutes - RBC Capital Markets macro and market strategy series – explores the latest financial market and economic developments. Listen today to hear high conviction insights from RBC’s desk strategists and research analysts.
…
continue reading
Our regular podcast from Lori Calvasina, Head of US Equity Strategy, that brings a fresh perspective and nuanced, data driven view on the forces shaping U.S. equity markets. Disclaimer: https://www.rbccm.com/en/policies-disclaimers.page
…
continue reading
Markets and sectors are transforming at a speed never seen before. Industries in Motion – a new serialized podcast from RBC Capital Markets – delivers highly differentiated insights and intelligence that looks at where now meets next, turning today’s faster-moving trends into tomorrow’s opportunities. Disclaimer: https://www.rbccm.com/en/policies-disclaimers.page
…
continue reading
Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team. Each month, Vito Sperduto, Global Head of M&A, and Larry Grafstein, Deputy Chairman, Global Investment Banking, break down the key trends, strategies and boardroom decisions shaping tomorrow's M&A landscape.
…
continue reading
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
Our podcast series explores the companies and leaders powering sustainable change and what the road ahead looks like for companies and investors in the sector.
…
continue reading
We will hear from experts from our Investment Services, Real Estate Management, Capital Markets, Valuation and Advisory services, Leasing, Occupier Services and Project Leaders business.
…
continue reading
This is The Real Pulse - a podcast series where RBC Capital Markets experts share their insights on the latest trends and opportunities in commercial real estate. Disclaimer: https://www.rbccm.com/en/policies-disclaimers.page
…
continue reading
The big things you need to know: First, 2Q24 earnings season is ending up solid. With most reports in, we highlight a few of the most interesting charts in our deck on earnings right now. Second, other updates on our high frequency indicators were generally positive for US equities and mixed for the rotation trade. We end the summer of 2024 with in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Business Jets: Market Dynamics Support Continued Growth
15:59
15:59
Play later
Play later
Lists
Like
Liked
15:59
In this episode of RBC’s Industries in Motion, Ken Herbert (Aerospace & Defense Analyst) and James McGarragle (Canadian Airlines & Aerospace and Diversified Industrials Analyst) discuss with Walter Spracklin (Canadian Research Management and Co-Head of Global Industrials Research) their positive outlook for the business jet industry, including an o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Fintechs’ Mood is More Upbeat than the Market’s
20:50
20:50
Play later
Play later
Lists
Like
Liked
20:50
RBC’s 9th Financial Technology Conference brought home how far the sector has evolved. In the latest episode of Industries in Motion, Financial Technology Analyst Dan Perlin highlights the diversity of today’s industry and explores the trends that indicate where it will go next.By RBC Capital Markets
…
continue reading
Three big things you need to know: First, last week’s price action relieved some pressures on the stock market, but didn’t solve its major problems. Second, earnings remain solid with no major deterioration in corporate tone. Third, we’d be more selective with value-oriented defensive sectors going forward.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Power, Utilities & Infrastructure: Powering global datacenter growth
15:28
15:28
Play later
Play later
Lists
Like
Liked
15:28
In this episode, Shelby Tucker (Managing Director, U.S. Power & Utilities Analyst), Elvira Scotto (Managing Director, Midstream & Pipelines Analyst) and Robert Kwan (Managing Director, Head of Global Power, Utilities & Infrastructure Research) at RBC Capital Markets discuss the potential for significant future growth in electricity consumption driv…
…
continue reading
We have seen very large market moves triggered by the US labour market report over the last few days that have also led to quite a few market participants changing their view on Fed rate cuts. We take a deeper dive into the data, highlight important questions that need answering and reiterate our rates call for the Fed and all other major central b…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bringing Private Investment to Energy Transition Innovation
26:26
26:26
Play later
Play later
Lists
Like
Liked
26:26
Private capital is critical to energy transition efforts, but much of it to date has been channeled to renewables and electric vehicles. What are the prospects of attracting funds to other sub-sectors, and early-stage innovators? In this episode of Strategic Alternatives, host Beatrix Pratte-Ness is joined by RBC specialists Ralph Ibendahl, Paul Be…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Monitoring Earnings, The Rotation Trade, and The Pullback
8:09
8:09
Play later
Play later
Lists
Like
Liked
8:09
Three big things you need to know: First, earnings season has been fine so far, and what we’ve read has kept us in the “tired goldilocks” camp. Second, we run through the latest updates for the indicators we’re monitoring in the rotation trade. We are mindful of headfakes, but think the trade may still have some room to run in the short term. We al…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
GenAI Activated: Key Debates and Topics in Software
19:16
19:16
Play later
Play later
Lists
Like
Liked
19:16
It may take years to play out, but generative AI is the next disruptive megatrend, says RBC analyst Matt Hedberg. Discover why he believes the biggest vendors and small software verticals both stand to be among the early tech winners.By RBC Capital Markets
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sentiment, Earnings, Rotation, and the US Election
5:30
5:30
Play later
Play later
Lists
Like
Liked
5:30
Four big things you need to know: First, investor sentiment has gotten as extreme as it did last August and this past March. Second, earnings season is off to a solid start, but we are still looking for some additional evidence in support of the idea that we’re seeing a durable leadership shift rather than a short-term rotation trade. Third, we’ve …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Shots-on-Goal Licensing Company Aims for Breakthroughs
13:52
13:52
Play later
Play later
Lists
Like
Liked
13:52
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.By RBC Capital Markets
…
continue reading
Markets have been pricing more rate cuts again on the back of somewhat weaker data releases, specifically in the US. Yet, central banks remain reticent in telegraphing rate cuts clearly. Can the latter change and make markets price in even more? Participants: Peter Schaffrik (Desk Strategy), Head of UK/European Rates & Economics Blake Gwinn (Desk S…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
2Q24 Reporting Season Is A Key Test For The Rotation Trade
5:26
5:26
Play later
Play later
Lists
Like
Liked
5:26
Two big things you need to know: First, we see 2Q24 reporting season as a key test for the rotation trade that attempted to start up again last week. Second, we remain worried about a pullback in the S&P 500 given the latest developments on our sentiment and positioning work, but timing seems a bit more complicated due to last week’s CPI print and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Biopharma Needs to Tell Better Stories on Novel Drugs
15:31
15:31
Play later
Play later
Lists
Like
Liked
15:31
Ronald Martell is a serial entrepreneur and biopharma veteran whose record includes the launch of Herceptin. He continues his mission to bring new drugs to patients with unmet medical needs. The CEO of Jasper Therapeutics explains his ambitions for his company’s new antibody therapy and for the future of the industry.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Under the Hood of Today’s Volatility and Options Markets
11:37
11:37
Play later
Play later
Lists
Like
Liked
11:37
On this episode of Strategic Alternatives, we share a rebroadcast of an iCapital Beyond 60/40 podcast episode, featuring Amy Wu Silverman, Managing Director and Equity Derivatives Strategist of RBC, in which she shares how options market trends can indicate public sentiment.By RBC Capital Markets
…
continue reading
With a combined deal value of $29bn under their belts this year, four CEOs reflect on what they’ve learned from their successes – and failures. Roberto Bellini (who sold BELLUS Health), Mark McKenna (Prometheus), Bill Meury (Karuna Therapeutics) and Dan O’Connor (Ambrx Biopharma) also consider the current market for biopharma M&A and what buyers ar…
…
continue reading
On this episode of Strategic Alternatives, we share a rebroadcast of the Meb Faber Show podcast episode, featuring Lori Calvasina, Head of US Equity Strategy at RBC Capital Markets, in which she explains why the US market has become more sentiment driven in the post COVID era. She shares her thoughts on the valuations of the top 10 stocks and the b…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Venture capital velocity: What’s driving renewed momentum in biotech?
35:03
35:03
Play later
Play later
Lists
Like
Liked
35:03
In biotech, a recovery is already well underway. Expected interest rate cuts and improving valuations across public and private markets are creating a compelling environment for deals, entrances, exits, and trades to take shape. In this episode, biotech venture capital experts assess the sector’s sharper focus on funding fundamental science, evolvi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Some of the Things We're Thinking About in US Equities as 2H24 Begins
8:10
8:10
Play later
Play later
Lists
Like
Liked
8:10
Three big things you need to know: First, we are lifting our YE 2024 S&P 500 price target to 5,700 from 5,300, which we would characterize as a nervous raise. Second, we think the risks of a short-term pullback in the S&P 500 are growing, similar to what occurred in April. Third, on positioning, we think it will be tough for the US equity market to…
…
continue reading
RBC Global Energy’s Nick Woodruff and Tim Perry discuss the trends shaping the landscape of commodities, energy, and infrastructure investments coming out of RBC’s 2024 Energy, Power & Infrastructure Conference (EPIC) in New York.By RBC Capital Markets
…
continue reading
Two G7 central banks have already cut – the ECB & BoC . Both should cut more as the year progresses while the BoE and Fed are likely to join the rate-cutting party later this year. At the other end of the spectrum is the RBA which is widely expected to keep the cash rate steady this year. Each country has its own nuances that will impact the timing…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Colliers Talks: Holding the Line: Why ESG investments in Real Estate Can't Stop
44:06
44:06
Play later
Play later
Lists
Like
Liked
44:06
The conversation focuses on the crucial role of ESG in driving business resilience and long-term success, while also highlighting the challenges of balancing competing interests in sustainable investing, including those of lenders, insurers, investors and tenants. This episode’s guests also discuss using a data-driven decision-making process to mak…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Steady C-Suite Confidence, What’s Baked in, Flows Argue for Rotation
6:22
6:22
Play later
Play later
Lists
Like
Liked
6:22
Three big things you need to know: First, the Duke CFO survey highlights how C-Suite confidence has remained steady, with monetary policy and automation in focus. Second, our new valuation stress test suggests the S&P 500 has been baking in optimistic views on inflation, interest rates, and the Fed. Third, recent funds flow trends point to a linger…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma Understands Phase One Data – But Does the Market?
25:30
25:30
Play later
Play later
Lists
Like
Liked
25:30
Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.By RBC Capital Markets
…
continue reading
RBC’s Markets in Motion is the weekly podcast from Lori Calvasina, Head of US Equity Strategy at RBC Capital Markets, highlighting her latest views on the US equity market. This week, we are excited to have Chris Louney, Commodity Strategist on RBC’s Global Commodity Strategy and MENA Research team, guest hosting this week’s episode while Lori is o…
…
continue reading
Three big things you need to know: First, the continued outperformance of mega cap Growth stocks has been logical, but still somewhat jarring to us. Second, Small Caps broke to clear new lows relative to Large Caps last week as risks piled up including a Fed that seems inclined to cut just once this year. We’d stay on the sidelines with Small Caps …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Davern Capital sees GLP-1 Opportunities Beyond Obesity
9:39
9:39
Play later
Play later
Lists
Like
Liked
9:39
Davern Capital’s founder, Elie Kobrin, approaches the biopharma market from a long/short perspective – but as a former doctor, he also speaks the language of medicine. He explains the fund’s approach and offers insights on hot topics in the current market.By RBC Capital Markets
…
continue reading
The BOC and ECB both kicked off long-awaited cutting cycles last week with questions about the depth and duration of these cycles likely to drive markets from here. But in other regions the case for pulling forward cuts is still somewhat weak. Where other central banks remain on hold, the trading environment might remain relatively rangebound into …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Betting on Healthcare’s Future Hits – and Misses
14:47
14:47
Play later
Play later
Lists
Like
Liked
14:47
As a healthcare-focused, market-neutral investor, Vince Aita stays close to new product developments with a view to identifying future successes and failures. At RBC’s Global Healthcare Conference, he offered his insights on everything from the future of obesity innovation to the impact of the IRA.By RBC Capital Markets
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Healthcare Equities Outlook: Opportunities for Outperformance
16:15
16:15
Play later
Play later
Lists
Like
Liked
16:15
This year has seen a pick-up in equity activity across healthcare, with a wider range of firms showing promise for value creation, and a stronger investor appetite for a pipeline of private companies that are set to go public. RBC’s John Kolz, John Hoffman, and Jason Levitz met at this year’s RBC Capital Markets Global Healthcare Conference to disc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Special Edition - A Conversation on Concentration, Retail, Energy & Utilities
23:19
23:19
Play later
Play later
Lists
Like
Liked
23:19
Special Edition: This is a special edition of RBC’s Markets in Motion podcast, recorded on June 4th, 2024, from the RBC Capital Markets 2024 Global Energy, Power & Infrastructure Conference (EPIC). Lori is joined by two of her road warrior colleagues, Ben Fisher (Midwest Equity Sales, specializes in macro) and Amy Wu Silverman (RBC’s Equity Derivat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Innovation and an Aging Population Drive MedTech
16:01
16:01
Play later
Play later
Lists
Like
Liked
16:01
The MedTech sector continues to grow in the U.S. as innovation in patient treatments and delivery meets increased demand from an aging population. Medical technology analyst Shagun Singh assesses key data points from the RBC Capital Markets’ Doctor Days events, looking at how the healthcare sector can empower investors to position themselves for fu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Old Leadership Bounces Back With A Vengeance
6:19
6:19
Play later
Play later
Lists
Like
Liked
6:19
Two big things you need to know: First, we highlight how and why old leadership in the US equity market has returned with a vengeance and run through our latest thoughts on what might get the rotation trade going again. Second, several of the gauges of investor sentiment and equity market risk that we track are keeping us neutral on stocks through …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing
20:39
20:39
Play later
Play later
Lists
Like
Liked
20:39
Personalized, targeted drugs and gene therapies are still at the forefront of medical innovation, as we discovered at RBC Capital Markets annual Doctor Days meetings. These insightful forums bring together key opinion leader clinicians and researchers from various therapeutic fields with institutional investors to discuss where opportunities lie, t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech with a Mission to Target Unmet Cancer Needs
13:37
13:37
Play later
Play later
Lists
Like
Liked
13:37
IDEAYA’s drug development programs center around addressing unmet patient needs. Its founder tells Pathfinders in Biopharma why he believes there has never been more opportunity for breakthroughs in the fight against cancer.By RBC Capital Markets
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Role of Sport in Supporting Youth Mental Wellbeing
26:36
26:36
Play later
Play later
Lists
Like
Liked
26:36
In recognition of Mental Health Awareness Month, Wil Snape-Rogers, Executive Director, and Danielle Hundt, Chief Program Officer, of Play Rugby USA, join Vito Sperduto to discuss how they are using the power of sport to help young people flourish—both mentally and physically.By RBC Capital Markets
…
continue reading
![Artwork](/static/images/128pixel.png)
1
U.S. in Prime Position as Energy Sector Eyes New Growth
26:18
26:18
Play later
Play later
Lists
Like
Liked
26:18
External forces are weighing heavily on energy markets in very different ways. While enforcement of merger competition rules puts strain on M&A deals, AI advances offer potential for both increased demand and business efficiencies. RBC Global Energy’s Nick Woodruff and Tim Perry consider the likely effects on the industry with host Vito Sperduto.…
…
continue reading
The big things you need to know: First, Small Caps are retesting their relative low vs. Large Caps once again, as Fed rate cut optimism has faded once again. We remain neutral Small vs. Large for now. Second, investor sentiment has almost returned to the highs in place to start the year (as well as the summer of 2023) on the AAII survey, reinforcin…
…
continue reading
Two developed market central banks have already cut - Riksbank and SNB - and the BoC, ECB and BoE should follow suit over the next couple of months. But the higher for longer theme is dominating the US rates market. The divergence in macro and policy is the major theme in rates markets. The other important theme is that despite Fed cuts being price…
…
continue reading
Oil and gas markets have reached a low- or no-growth business model, yet recent months have produced a surge in M&A activity not seen for a generation. Tim Perry and Nick Woodruff, of RBC’s Global Energy team, join Vito Sperduto to take the temperature of the sector and analyze the current state of energy valuations.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Colliers Talks: Behind the Data – The Impact of Population and Demographics on Commercial Real Estate
41:07
41:07
Play later
Play later
Lists
Like
Liked
41:07
Jacobs and Ivankovic cover the following topics: Over the last few years, Canada has seen more immigration to secondary or tertiary markets, and particularly in Alberta, which has been trying to attract more residents. Immigration is not only changing the number of Canadian consumers, but is also shifting how people consume products and the types o…
…
continue reading
The big things you need to know: Three big things you need to know: First, Tech has bounced back on performance and earnings revisions but valuations remain a problem. Second, valuations more broadly have started to look less appealing. Third, other updates in our high frequency indicators highlight how pendulums have swung on a few different front…
…
continue reading
Markets have been ultra-sensitive to data for some time now, going back to market pricing for hikes starting in late 2021. More recently, several strong US inflation prints have de-railed the potential for upcoming Fed cuts, while upside surprises have occurred in Canada, the UK and Australia in the recent weeks. Will these data points be determina…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Earnings Ending Up Fine with a Twist, Bulls Bounce Back
5:44
5:44
Play later
Play later
Lists
Like
Liked
5:44
The big things you need to know: First, reporting season has ended up looking just fine on the stats, with one twist at the end. Second, we update our rundown of key themes on earnings calls. Third, net bulls on the AAII survey bounced back last week as 10-year yields decoupled from their 2023 spike, hopes for Fed cuts returned, and flows to US equ…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How private capital is reshaping Europe’s investment landscape
14:56
14:56
Play later
Play later
Lists
Like
Liked
14:56
John Kolz, Global Co-Head, Equity Capital Markets, Paul Betts, Managing Director, M&A, Europe and Beatrix Pratte-Ness, Associate, M&A, Europe, explore key themes shaping private placement transactions across Europe, and the interplay between private and public markets and M&A activity.By RBC Capital Markets
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates on Reporting Season, Sentiment, Small Caps
7:17
7:17
Play later
Play later
Lists
Like
Liked
7:17
The big things you need to know: Three big things you need to know: First, after a weak start to 1Q24 reporting season, it has settled into a groove on the stats. Second, we review our thoughts on key themes on company earnings calls so far. Third, we highlight what’s jumping out on our high frequency indicators. This includes our main sentiment in…
…
continue reading
The latest resilience in the US has kick started a debate about how much other regions that appear to not show the same kind of underlying strength can diverge from the Fed and cut rates regardless. We see the best chances of that happening in Canada, but also provide updated views on the BoE, ECB and RBA. Meanwhile, the gyrations in the JPY keep i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Analyst Survey Results Point To Optimism & Rotation, US Sector Call Changes
4:26
4:26
Play later
Play later
Lists
Like
Liked
4:26
The big things you need to know: First, we’ve just completed our quarterly survey of RBC’s equity analysts around the globe and found that optimism on performance persists for most sectors and coverage regions, despite the challenges associated with higher interest rates. Second, with a fresh set of survey results in hand we are making three change…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sentiment, Companies Beating Consensus, and Growth Take a Hit
9:31
9:31
Play later
Play later
Lists
Like
Liked
9:31
The big things you need to know: First, investor sentiment has taken a bit of a hit, but it’s too early to say the pullback is over. Second, while we continue to expect the pullback to bottom out in the 5-10% range vs. recent highs, we’ve taken a look at S&P 500 performance around recent wars to gauge potential downside risks if we are wrong in tha…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Insurance’s Resurgence and BDC Competition
15:38
15:38
Play later
Play later
Lists
Like
Liked
15:38
Late 2023 saw a pick-up in equity capital markets activity in financial services. Insurance and business development corporations show particular promise for 2024, while there is keen investor appetite for a pipeline of alternative asset managers set to go public. RBC’s J.T. Deignan, MD and Head of Real Estate and Financial Institutions Equity Capi…
…
continue reading